301033 迈普医学
已收盘 07-02 15:00:00
资讯
新帖
简况
7月2日迈普医学涨5.41%，大成价值增长混合A基金重仓该股
证券之星 · 07-02 16:47
7月2日迈普医学涨5.41%，大成价值增长混合A基金重仓该股
迈普医学（301033）披露发行股份及支付现金购买易介医疗100%股权并募集配套资金报告书（草案）（注册稿），6月30日股价下跌4.43%
证券之星 · 06-30 17:53
迈普医学（301033）披露发行股份及支付现金购买易介医疗100%股权并募集配套资金报告书（草案）（注册稿），6月30日股价下跌4.43%
6月29日迈普医学涨20.00%，大成价值增长混合A基金重仓该股
证券之星 · 06-29
6月29日迈普医学涨20.00%，大成价值增长混合A基金重仓该股
迈普医学：相关报道相关内容不属实
证券之星 · 06-29
迈普医学：相关报道相关内容不属实
异动快报：迈普医学（301033）6月29日13点26分触及涨停板
证券之星 · 06-29
异动快报：迈普医学（301033）6月29日13点26分触及涨停板
迈普医学(301033.SZ)3.35亿并购易介医疗过会 为创业板改革落地后首单过会的收购未盈利标的重组项目
智通财经 · 06-26
迈普医学(301033.SZ)3.35亿并购易介医疗过会 为创业板改革落地后首单过会的收购未盈利标的重组项目
迈普医学3.35亿并购上会在即，业绩承诺能否实现引关注
北京商报 · 06-23
迈普医学3.35亿并购上会在即，业绩承诺能否实现引关注
每周股票复盘：迈普医学（301033）拟购易介医疗100%股权
证券之星 · 06-21
每周股票复盘：迈普医学（301033）拟购易介医疗100%股权
迈普医学（301033）披露重组审核问询函回复（修订稿），6月16日股价下跌2.37%
证券之星 · 06-16
迈普医学（301033）披露重组审核问询函回复（修订稿），6月16日股价下跌2.37%
开源证券：首次覆盖迈普医学给予买入评级
证券之星 · 06-10
开源证券：首次覆盖迈普医学给予买入评级
6月8日迈普医学跌6.04%，大成价值增长混合A基金重仓该股
证券之星 · 06-08
6月8日迈普医学跌6.04%，大成价值增长混合A基金重仓该股
迈普医学：未单独披露止血纱产品具体情况
证券之星 · 06-08
迈普医学：未单独披露止血纱产品具体情况
迈普医学：截至目前公司不存在被突击飞检出具重大不符合项的情况
证券之星 · 06-04
迈普医学：截至目前公司不存在被突击飞检出具重大不符合项的情况
6月1日迈普医学发布公告，股东减持84.09万股
证券之星 · 06-01
6月1日迈普医学发布公告，股东减持84.09万股
股市必读：迈普医学（301033）今年截至5月29日累计跌幅已超30%
证券之星 · 06-01
股市必读：迈普医学（301033）今年截至5月29日累计跌幅已超30%
5月28日迈普医学现1笔折价18.1%的大宗交易 合计成交463.6万元
证券之星 · 05-28
5月28日迈普医学现1笔折价18.1%的大宗交易 合计成交463.6万元
迈普医学：未单独披露止血纱产品收入
证券之星 · 05-27
迈普医学：未单独披露止血纱产品收入
迈普医学（301033）披露本次交易加期评估报告，5月26日股价下跌2.02%
证券之星 · 05-26
迈普医学（301033）披露本次交易加期评估报告，5月26日股价下跌2.02%
迈普医学（301033）披露2025年年度权益分派实施公告，5月25日股价下跌2.3%
证券之星 · 05-25
迈普医学（301033）披露2025年年度权益分派实施公告，5月25日股价下跌2.3%
股市必读：迈普医学（301033）今年截至5月21日累计跌幅已超25%
证券之星 · 05-22
股市必读：迈普医学（301033）今年截至5月21日累计跌幅已超25%
公司概况
公司名称：
广州迈普再生医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-07-26
主营业务：
广州迈普再生医学科技股份有限公司的主营业务是医疗器械的研发、生产与销售。公司的主要产品是人工硬脑（脊）膜补片、颅颌面修补及固定系统、可吸收再生氧化纤维素、硬脑膜医用胶、3D打印设备、技术服务。
发行价格：
15.14
{"stockData":{"symbol":"301033","market":"SZ","secType":"STK","nameCN":"迈普医学","latestPrice":55.5,"timestamp":1782975825000,"preClose":52.65,"halted":0,"volume":4206634,"delay":0,"changeRate":0.0541,"floatShares":56353700,"shares":67049600,"eps":1.6359,"marketStatus":"已收盘","change":2.85,"latestTime":"07-02 15:00:00","open":53.27,"high":58.68,"low":52.66,"amount":236000000,"amplitude":0.1143,"askPrice":55.5,"askSize":34,"bidPrice":55.49,"bidSize":15,"shortable":0,"etf":0,"ttmEps":1.6359,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783042200000},"marketStatusCode":5,"adr":0,"adjPreClose":52.65,"symbolType":"stock","openAndCloseTimeList":[[1782955800000,1782963000000],[1782968400000,1782975600000]],"highLimit":57.92,"lowLimit":47.39,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":67049620,"isCdr":false,"pbRate":4.31,"roa":"--","peRate":33.926279,"roe":"2.56%","epsLYR":1.71,"committee":0.079208,"marketValue":3721000000,"turnoverRate":0.0746,"status":0,"floatMarketCap":3128000000},"requestUrl":"/m/hq/s/301033/wiki","defaultTab":"wiki","newsList":[{"id":"2648815503","title":"7月2日迈普医学涨5.41%，大成价值增长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648815503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648815503?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:47","pubTimestamp":1782982064,"startTime":"0","endTime":"0","summary":"证券之星消息，7月2日迈普医学涨5.41%，收盘报55.5元，换手率7.46%，成交量4.21万手，成交额2.36亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为大成基金的大成价值增长混合A。大成价值增长混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200027397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647534511","title":"迈普医学（301033）披露发行股份及支付现金购买易介医疗100%股权并募集配套资金报告书（草案）（注册稿），6月30日股价下跌4.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647534511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647534511?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:53","pubTimestamp":1782813192,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，迈普医学报收于51.79元，较前一交易日下跌4.43%，最新总市值为34.72亿元。近日，广州迈普再生医学科技股份有限公司披露《发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（草案）（注册稿）》。公告显示，公司拟通过发行股份及支付现金的方式，向泽新医疗等10名交易对方购买易介医疗100%股权，并募集配套资金。本次交易构成关联交易，不构成重大资产重组，也不构成重组上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","159891","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322120","title":"6月29日迈普医学涨20.00%，大成价值增长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322120","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322120?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:53","pubTimestamp":1782723212,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日迈普医学涨20.00%，收盘报54.19元，换手率5.27%，成交量2.97万手，成交额1.49亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为大成基金的大成价值增长混合A。大成价值增长混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647297373","title":"迈普医学：相关报道相关内容不属实","url":"https://stock-news.laohu8.com/highlight/detail?id=2647297373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647297373?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:38","pubTimestamp":1782718682,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学06月29日在投资者关系平台上答复投资者关心的问题。请问：1. 该报道是否属实？经核实，您提及的相关报道相关内容不属实。公司目前不存在应披露而未披露的重大事项，公司所有重大事项均会通过法定披露渠道发布官方公告，请您以公司正式公告为准。资本市场存在不确定性，提醒您审慎判断，留意相关投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900017762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647235213","title":"异动快报：迈普医学（301033）6月29日13点26分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647235213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647235213?lang=zh_cn&edition=full","pubTime":"2026-06-29 13:30","pubTimestamp":1782711058,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，13点26分迈普医学（301033）触及涨停板。其所属行业医疗器械目前上涨。领涨股为佰仁医疗。该股为口腔，医疗器械，脑科学概念热股，当日口腔概念上涨3.52%，医疗器械概念上涨2.99%，脑科学概念上涨1.89%。6月26日的资金流向数据方面，主力资金净流出64.29万元，占总成交额1.12%，游资资金净流出30.75万元，占总成交额0.54%，散户资金净流入95.04万元，占总成交额1.65%。近5日资金流向一览见下表：迈普医学主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900016388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646506873","title":"迈普医学(301033.SZ)3.35亿并购易介医疗过会 为创业板改革落地后首单过会的收购未盈利标的重组项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2646506873","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646506873?lang=zh_cn&edition=full","pubTime":"2026-06-26 21:02","pubTimestamp":1782478975,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月26日，迈普医学发行股份及支付现金购买资产项目通过深交所并购重组委会议，这是4月10日创业板改革落地后首单过会的收购未盈利标的重组项目。重大资产重组报告书显示，迈普医学拟通过发行股份及支付现金的方式向泽新医疗等10名交易对方购买易介医疗100%股权。本次交易完成后易介医疗将成为迈普医学全资子公司。迈普医学募集配套融资拟发行金额为1.3358亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"迈普医学(301033.SZ)3.35亿并购易介医疗过会 为创业板改革落地后首单过会的收购未盈利标的重组项目","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645834194","title":"迈普医学3.35亿并购上会在即，业绩承诺能否实现引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2645834194","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645834194?lang=zh_cn&edition=full","pubTime":"2026-06-23 21:24","pubTimestamp":1782221040,"startTime":"0","endTime":"0","summary":"迈普医学并购广州易介医疗科技有限公司事项即将上会。不过，标的公司目前业绩持续亏损，在此背景下，业绩承诺方做出的业绩承诺合理性与可实现性难免引发市场关注。而在重大资产重组报告书中，也提示了标的公司业绩承诺可能无法实现的风险。 财务数据显示，2025年迈普医学实现营业收入约3.69亿元，同比增长32.46%；对应实现归属净利润约1.13亿元，同比增长43.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-23/doc-iniemfsm6351100.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-23/doc-iniemfsm6351100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645309619","title":"每周股票复盘：迈普医学（301033）拟购易介医疗100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2645309619","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645309619?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:15","pubTimestamp":1781982913,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，迈普医学报收于48.9元，较上周的48.14元上涨1.58%。本周关注点来自交易信息汇总：迈普医学拟发行股份及支付现金购买易介医疗100%股权，交易价格为33,484.94万元。第三届董事会第二十三次会议审议通过调整发行股份及支付现金购买广州易介医疗科技有限公司100%股权并募集配套资金的方案。华泰联合证券发布独立财务顾问报告（修订稿），公司拟购买易介医疗100%股权，交易价格为33,484.94万元，构成关联交易，不构成重大资产重组或重组上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643756146","title":"迈普医学（301033）披露重组审核问询函回复（修订稿），6月16日股价下跌2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643756146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643756146?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:35","pubTimestamp":1781606139,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，迈普医学报收于48.59元，较前一交易日下跌2.37%，最新总市值为32.58亿元。公告显示，公司就深交所关于其发行股份及支付现金购买资产并募集配套资金申请的审核问询函作出回复，披露了本次交易的必要性、标的资产业绩与经营情况、评估作价、销售费用、交易对方、交易方案、募集资金使用、整合管控等事项。标的资产报告期内收入增长较快，但仍处于亏损状态，已多次通过增资引入外部投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600035222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642044814","title":"开源证券：首次覆盖迈普医学给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2642044814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642044814?lang=zh_cn&edition=full","pubTime":"2026-06-10 14:30","pubTimestamp":1781073039,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,陈峻,石启正近期对迈普医学进行研究并发布了研究报告《公司首次覆盖报告：新产品放量在即，海外市场蓄势待发》，首次覆盖迈普医学给予买入评级。首次覆盖，给予“买入”评级。 风险提示：核心技术迭代风险、下游产品动销风险、研发风险最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为70.85。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000020933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641009871","title":"6月8日迈普医学跌6.04%，大成价值增长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641009871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641009871?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:05","pubTimestamp":1780909528,"startTime":"0","endTime":"0","summary":"证券之星消息，6月8日迈普医学跌6.04%创60日新低，收盘报45.77元，换手率2.13%，成交量1.2万手，成交额5579.26万元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为大成基金的大成价值增长混合A。大成价值增长混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641013081","title":"迈普医学：未单独披露止血纱产品具体情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2641013081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641013081?lang=zh_cn&edition=full","pubTime":"2026-06-08 15:06","pubTimestamp":1780902376,"startTime":"0","endTime":"0","summary":"公司已在前期回复，公司按规定在2025年年度报告第三节管理层讨论与分析之四、主营业务分析之“2、收入与成本”部分披露了分产品的营业收入情况，其中包括可吸收再生氧化纤维素及硬脑膜医用胶产品收入情况，未单独披露止血纱产品具体情况。2023年以来，公司止血纱及硬脑膜医用胶两类新产品得到广大投资者的持续关注，为方便投资者持续查看新产品整体收入增速情况，保持信息披露的连贯性和一致性，公司采用了合并披露的方式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800013605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640139640","title":"迈普医学：截至目前公司不存在被突击飞检出具重大不符合项的情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2640139640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640139640?lang=zh_cn&edition=full","pubTime":"2026-06-04 11:33","pubTimestamp":1780543997,"startTime":"0","endTime":"0","summary":"投资者提问：董秘你好：投资者问“欧盟MDR突击飞检公司被出具三项重大不符合项，同时公司4月29日收到黄埔区劳动监察限期整改令，至今逾期未落实问题”，公司回复“公司运营正常，重视合规建设，重视渠道管理，不存在体系合规和渠道方面的不良事件”，问题回答了，好像又啥也没回答。请答复问题：1. 是否存在黄埔区劳动监察的限期整改指令？截至目前，公司不存在被突击飞检出具重大不符合项的情况，亦无劳动监察限期整改情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400014332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640795974","title":"6月1日迈普医学发布公告，股东减持84.09万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640795974","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640795974?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:01","pubTimestamp":1780315285,"startTime":"0","endTime":"0","summary":"证券之星消息，6月1日迈普医学发布公告《迈普医学:关于公司股东减持股份计划实施完成的公告》，其股东唐莹于2026年3月10日至2026年5月28日间合计减持84.09万股，占公司目前总股本的1.2541%，变动期间该股股价下跌22.28%，截止5月28日收盘报51.28元。股东增减持详情见下表：根据迈普医学2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100035965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640985107","title":"股市必读：迈普医学（301033）今年截至5月29日累计跌幅已超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640985107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640985107?lang=zh_cn&edition=full","pubTime":"2026-06-01 03:48","pubTimestamp":1780256893,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，迈普医学报收于49.75元，下跌2.98%，换手率1.82%，成交量1.03万手，成交额5168.06万元。交易信息汇总股价提醒5月29日迈普医学收盘报49.75元，跌2.98%，当日成交5168.06万元。该股已连续5日下跌，当年累计跌幅30.09%。前10个交易日主力资金累计净流出866.58万元，期间股价累计下跌14.45%；融资余额累计减少646.7万元，融券余量累计增加0股。近90天内共有5家机构对该股给出评级，其中买入评级4家，增持评级1家，机构目标均价为71.87元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100001608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638669418","title":"5月28日迈普医学现1笔折价18.1%的大宗交易 合计成交463.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638669418","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638669418?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:26","pubTimestamp":1779960413,"startTime":"0","endTime":"0","summary":"证券之星消息，5月28日迈普医学发生大宗交易，交易数据如下：大宗交易成交价格42元，相对当日收盘价折价18.1%，成交11.04万股，成交金额463.6万元，买方营业部为财信证券股份有限公司东莞南城证券营业部，卖方营业部为招商证券股份有限公司深圳文锦渡深润大厦证券营业部。近三个月该股共发生2笔大宗交易，合计成交1704.0手，折价成交2笔。截至2026年5月28日收盘，迈普医学报收于51.28元，上涨0.08%，换手率1.29%，成交量7293.0手，成交额3718.98万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800030874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638577688","title":"迈普医学：未单独披露止血纱产品收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2638577688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638577688?lang=zh_cn&edition=full","pubTime":"2026-05-27 15:42","pubTimestamp":1779867733,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学05月26日在投资者关系平台上答复投资者关心的问题。公司按规定在2025年年度报告第三节管理层讨论与分析之四、主营业务分析之“2、收入与成本”部分披露了分产品的营业收入情况，其中包括可吸收再生氧化纤维素及硬脑膜医用胶产品收入情况，未单独披露止血纱产品具体情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700026351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638518804","title":"迈普医学（301033）披露本次交易加期评估报告，5月26日股价下跌2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638518804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638518804?lang=zh_cn&edition=full","pubTime":"2026-05-26 17:33","pubTimestamp":1779787996,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，迈普医学报收于51.52元，较前一交易日下跌2.02%，最新总市值为34.54亿元。近日，迈普医学披露《关于本次交易所涉评估报告加期的公告》。因原评估报告评估基准日即将超过一年有效期，公司聘请联信评估以2025年11月30日为加期评估基准日进行加期评估，出具了新的评估报告。公司董事会及相关专门委员会已审议通过加期评估报告。本次交易仍以原评估报告结果作为定价依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600030162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638532146","title":"迈普医学（301033）披露2025年年度权益分派实施公告，5月25日股价下跌2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638532146","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638532146?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:43","pubTimestamp":1779705792,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，迈普医学报收于52.58元，较前一交易日下跌2.3%，最新总市值为35.25亿元。该股当日开盘53.77元，最高54.11元，最低51.71元，成交额达5591.45万元，换手率为1.89%。公司于近日披露《2025年年度权益分派实施公告》。公告显示，迈普医学2025年年度权益分派方案已获2026年5月19日召开的年度股东会审议通过。股权登记日为2026年5月29日，除权除息日为2026年6月1日。公司回购专用账户中的股份不参与本次权益分派。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637351576","title":"股市必读：迈普医学（301033）今年截至5月21日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637351576","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637351576?lang=zh_cn&edition=full","pubTime":"2026-05-22 03:50","pubTimestamp":1779393022,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，迈普医学报收于51.71元，下跌7.31%，换手率3.58%，成交量2.02万手，成交额1.09亿元。当日关注点来自交易信息汇总：迈普医学5月21日收盘报51.71元，跌7.31%，当日成交201.58万元，年内累计跌幅达25.84%。前10个交易日资金流向情况：主力资金累计净流入178.31万元，股价累计下跌9.25%；融资余额累计减少266万元，融券余量累计增加0股。资金流向5月21日主力资金净流出376.7万元；游资资金净流出559.03万元；散户资金净流入935.74万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200005147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783029414655,"stockEarnings":[{"period":"1week","weight":0.1721},{"period":"1month","weight":0.1401},{"period":"3month","weight":-0.0721},{"period":"6month","weight":-0.1661},{"period":"1year","weight":-0.0867},{"period":"ytd","weight":-0.1661}],"compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0113},{"period":"3month","weight":0.0384},{"period":"6month","weight":0.0151},{"period":"1year","weight":0.1662},{"period":"ytd","weight":0.0151}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州迈普再生医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"7567人(较上一季度增加23.93%)","perCapita":"7447股","listingDate":"2021-07-26","address":"广东省广州市黄埔区崖鹰石路3号","registeredCapital":"6704万元","survey":" 广州迈普再生医学科技股份有限公司的主营业务是医疗器械的研发、生产与销售。公司的主要产品是人工硬脑（脊）膜补片、颅颌面修补及固定系统、可吸收再生氧化纤维素、硬脑膜医用胶、3D打印设备、技术服务。","listedPrice":15.14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈普医学,301033,迈普医学股票,迈普医学股票老虎,迈普医学股票老虎国际,迈普医学行情,迈普医学股票行情,迈普医学股价,迈普医学股市,迈普医学股票价格,迈普医学股票交易,迈普医学股票购买,迈普医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}